Johnny Xiang Li, MD
Glaucoma Specialist · New York
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Li’s office at (212) 732-0073 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$4,237
Medicare paid this office $4,237 for 27 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient problem focused exam of visual system | 18 | $1,188 | $63 |
| Exam of visual field with extended testing | 14 | $798 | $57 |
Who their Medicare patients are
27 Original Medicare patients in 2024. Average age 80 · Under 65 0% · Health risk score 1.25. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 75% · Diabetes 56%.
The office billed $12,080, Medicare allowed $6,008 and paid $4,237; for 72 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 27 | 72 | 80 | 1.25 | $12,080 | $4,237 |
| 2022 | 63 | 82 | 77 | 0.97 | $30,520 | $2,345 |
| 2021 | 72 | 98 | 78 | 0.83 | $54,970 | $6,799 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2022: 2 services
| Established patient problem focused exam of visual system | 34 | $924 | $27 |
| Imaging of optic nerve | 15 | $293 | $20 |
2021: 4 services
| Established patient problem focused exam of visual system | 31 | $2,554 | $82 |
| Exam of visual field with extended testing | 17 | $1,023 | $60 |
| Photography of the retina | 16 | $561 | $35 |
| Imaging of optic nerve | 15 | $502 | $33 |
Medicaid work
$4,468 in 2024
Medicaid paid $4,468 for 90 billed services this clinician did in 2024, up to 29 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 33 | $2,745 |
| GONIOSCOPY | 30 | $769 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 15 | $504 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 12 | $450 |
| 2024 | 90 | 4 | 29 | $4,468 |
Drugs they prescribed that Part D paid
$366,437
Pharmacies billed $366,437 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,088) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
1,328 generic and fewer than 11 brand-name prescriptions · $366,437 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Restasis | 97 | $105,444 | $1,087 |
| Xiidra | 59 | $57,444 | $974 |
| Lumigan | 52 | $31,882 | $613 |
| Tyrvaya | 46 | $28,574 | $621 |
| Combigan | 58 | $23,635 | $408 |
See all 24 drugs
| Restasis | 97 | $105,444 | $1,087 |
| Xiidra | 59 | $57,444 | $974 |
| Lumigan | 52 | $31,882 | $613 |
| Tyrvaya | 46 | $28,574 | $621 |
| Combigan | 58 | $23,635 | $408 |
| Iyuzeh | 49 | $15,458 | $315 |
| Vyzulta | 29 | $14,259 | $492 |
| Cyclosporine | 27 | $10,277 | $381 |
| Simbrinza | 42 | $9,855 | $235 |
| Bepotastine Besilate | 57 | $8,721 | $153 |
| Rhopressa | 19 | $5,950 | $313 |
| Timolol Maleate | 248 | $5,027 | $20 |
| Alphagan P | 22 | $4,996 | $227 |
| Travoprost | 57 | $4,575 | $80 |
| Latanoprost | 513 | $4,322 | $8 |
| Brimonidine Tartrate-Timolol | 24 | $3,337 | $139 |
| Brimonidine | 29 | $3,184 | $110 |
| Prednisolone Acetate | 40 | $2,164 | $54 |
| Brinzolamide | 13 | $1,992 | $153 |
| Erythromycin | 172 | $1,950 | $11 |
| Dorzolamide-Timolol | 140 | $1,765 | $13 |
| Cromolyn | 102 | $1,227 | $12 |
| Azelastine | 69 | $819 | $12 |
| Dorzolamide | 26 | $530 | $20 |
Year by year
| 2024 | 2,088 | 411 | 0% (0) | None | $366,437 |
| 2023 | 1,995 | 569 | 0% (0) | 37% | $424,741 |
| 2022 | 4,417 | 1,011 | 0% (0) | 47% | $762,193 |
| 2021 | 1,604 | 615 | 0% (0) | 50% | $234,686 |
| 2020 | 518 | 116 | 0% (0) | 36% | $26,603 |
| 2019 | 418 | 92 | 0% (0) | 38% | $32,527 |
| 2018 | 90 | 29 | None | 39% | $6,755 |
| 2017 | 35 | 18 | 0% (0) | None | $1,637 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 26 drugs
| Restasis | 101 | $139,742 | $1,384 |
| Lumigan | 86 | $52,260 | $608 |
| Xiidra | 27 | $48,414 | $1,793 |
| Combigan | 52 | $16,875 | $325 |
| Rhopressa | 38 | $16,404 | $432 |
| Alphagan P | 54 | $15,261 | $283 |
| Vyzulta | 32 | $14,549 | $455 |
| Latanoprost | 538 | $13,075 | $24 |
| Bepotastine Besilate | 29 | $9,106 | $314 |
| Travoprost | 41 | $9,041 | $221 |
| Brinzolamide | 21 | $8,172 | $389 |
| Simbrinza | 30 | $7,219 | $241 |
| Prednisolone Acetate | 58 | $5,028 | $87 |
| Brimonidine Tartrate-Timolol | 18 | $5,019 | $279 |
| Dorzolamide-Timolol | 146 | $4,925 | $34 |
| Timolol Maleate | 213 | $4,438 | $21 |
| Besivance | 11 | $3,454 | $314 |
| Brimonidine | 47 | $3,100 | $66 |
| Acetazolamide Er | 15 | $2,465 | $164 |
| Azelastine | 48 | $1,718 | $36 |
| Moxifloxacin | 20 | $1,680 | $84 |
| Olopatadine | 86 | $1,679 | $20 |
| Erythromycin | 99 | $1,359 | $14 |
| Dorzolamide | 35 | $1,333 | $38 |
| Pilocarpine | 11 | $641 | $58 |
| Cromolyn | 18 | $269 | $15 |
2022: 36 drugs
| Lumigan | 254 | $112,720 | $444 |
| Rhopressa | 160 | $68,899 | $431 |
| Combigan | 162 | $59,194 | $365 |
| Alphagan P | 123 | $47,421 | $386 |
| Restasis | 43 | $44,464 | $1,034 |
| Rocklatan | 93 | $43,998 | $473 |
| Brinzolamide | 112 | $38,144 | $341 |
| Travoprost | 170 | $36,436 | $214 |
| Latanoprost | 1,093 | $25,884 | $24 |
| Azopt | 53 | $25,024 | $472 |
| Simbrinza | 74 | $22,563 | $305 |
| Brimonidine | 319 | $21,117 | $66 |
| Vyzulta | 34 | $18,583 | $547 |
| Methazolamide | 35 | $17,556 | $502 |
| Timoptic Ocudose | 25 | $15,844 | $634 |
| Zioptan | 46 | $14,401 | $313 |
| Dorzolamide-Timolol | 401 | $13,841 | $35 |
| Dorzolamide-Timolol | 73 | $11,590 | $159 |
| Prednisolone Acetate | 178 | $10,598 | $60 |
| Cosopt Pf | 28 | $10,577 | $378 |
| Timolol Maleate | 321 | $10,540 | $33 |
| Travatan Z | 19 | $9,946 | $523 |
| Timolol Maleate | 22 | $9,019 | $410 |
| Betoptic S | 14 | $7,249 | $518 |
| Dorzolamide | 183 | $6,351 | $35 |
| Pilocarpine | 77 | $5,754 | $75 |
| Bromsite | 11 | $4,670 | $425 |
| Brimonidine Tartrate-Timolol | 19 | $3,860 | $203 |
| Betimol | 13 | $3,815 | $293 |
| Fluorometholone | 30 | $3,300 | $110 |
| Loteprednol Etabonate | 17 | $3,164 | $186 |
| Acetazolamide Er | 28 | $2,899 | $104 |
| Acetazolamide | 14 | $1,158 | $83 |
| Ketorolac Tromethamine | 19 | $907 | $48 |
| Moxifloxacin | 17 | $833 | $49 |
| Erythromycin | 12 | $155 | $13 |
2021: 23 drugs
| Lumigan | 89 | $40,605 | $456 |
| Combigan | 68 | $23,409 | $344 |
| Rhopressa | 41 | $16,575 | $404 |
| Alphagan P | 45 | $12,887 | $286 |
| Prednisolone Acetate | 189 | $11,615 | $61 |
| Restasis | 13 | $11,587 | $891 |
| Rocklatan | 26 | $10,577 | $407 |
| Travoprost | 47 | $10,528 | $224 |
| Azopt | 22 | $10,209 | $464 |
| Brimonidine | 110 | $9,246 | $84 |
| Latanoprost | 331 | $8,441 | $26 |
| Brinzolamide | 20 | $8,229 | $411 |
| Simbrinza | 29 | $8,090 | $279 |
| Zioptan | 16 | $4,865 | $304 |
| Dorzolamide-Timolol | 132 | $4,765 | $36 |
| Timolol Maleate | 89 | $3,928 | $44 |
| Dorzolamide-Timolol | 20 | $3,673 | $184 |
| Flurbiprofen | 57 | $3,280 | $58 |
| Dorzolamide | 64 | $2,232 | $35 |
| Pilocarpine | 31 | $1,994 | $64 |
| Fluorometholone | 12 | $1,189 | $99 |
| Ketorolac Tromethamine | 25 | $920 | $37 |
| Olopatadine | 11 | $186 | $17 |
2020: 9 drugs
| Alphagan P | 13 | $4,288 | $330 |
| Prednisolone Acetate | 64 | $3,840 | $60 |
| Latanoprost | 199 | $2,306 | $12 |
| Dorzolamide-Timolol | 42 | $1,406 | $33 |
| Timolol Maleate | 52 | $1,115 | $21 |
| Dorzolamide | 32 | $944 | $30 |
| Brimonidine | 31 | $765 | $25 |
| Ketorolac Tromethamine | 16 | $615 | $38 |
| Flurbiprofen | 11 | $532 | $48 |
2019: 10 drugs
| Combigan | 23 | $5,212 | $227 |
| Alphagan P | 12 | $4,228 | $352 |
| Travatan Z | 17 | $3,145 | $185 |
| Brimonidine | 41 | $2,321 | $57 |
| Prednisolone Acetate | 36 | $1,813 | $50 |
| Latanoprost | 126 | $1,452 | $12 |
| Dorzolamide | 27 | $685 | $25 |
| Flurbiprofen | 12 | $628 | $52 |
| Dorzolamide-Timolol | 28 | $613 | $22 |
| Timolol Maleate | 46 | $444 | $10 |
2018: 2 drugs
| Brimonidine | 14 | $830 | $59 |
| Latanoprost | 25 | $241 | $10 |
Money from drug and device companies
$820 in 2025
| 2025 | 3 | 12 | None | $820 |
| 2024 | 9 | 18 | None | $487 |
| 2023 | 4 | 6 | None | $479 |
| 2022 | 2 | 2 | None | $37 |
| 2021 | 2 | 4 | None | $375 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alcon Vision | Hydrus Microstent | $651 | 10 payments
|
| Abbvie | Lumigan | $144 | 1 payment
|
| Bausch & Lomb Americas | Vyzulta | $25 | 1 payment
|
See all 12 published payments
| Alcon Vision | Meals · 2025-11-07 | Unity | $50 |
| Alcon Vision | Meals · 2025-08-19 | Tryptyr | $18 |
| Alcon Vision | Meals · 2025-08-18 | Tryptyr | $3 |
| Alcon Vision | Meals · 2025-07-01 | Hydrus Microstent | $33 |
| Bausch & Lomb Americas | Meals · 2025-06-16 | Vyzulta | $25 |
| Alcon Vision | Meals · 2025-05-01 | Hydrus Microstent | $65 |
| Abbvie | Meals · 2025-04-10 | Lumigan | $144 |
| Alcon Vision | Meals · 2025-04-03 | Voyager Dslt | $150 |
| Alcon Vision | Meals · 2025-03-18 | Hydrus Microstent | $142 |
| Alcon Vision | Meals · 2025-03-13 | Clareon | $6 |
| Alcon Vision | Meals · 2025-02-27 | Hydrus Microstent | $35 |
| Alcon Vision | Meals · 2025-02-10 | Clareon Panoptix Pro | $148 |
See earlier years (2024, 2023, 2022, 2021)
2024: $487
| Alcon Vision | Clareon | $197 | 6 payments
|
| Glaukos | Istent Trabecular Micro-Bypass System Model Is3 | $85 | 2 payments
|
| Oyster Point Pharma | Tyrvaya | $55 | 3 payments
|
| Thea Pharma | Iyuzeh | $36 | 2 payments
|
| Tarsus Pharmaceuticals | Xdemvy | $31 | 1 payment
|
| Dompe US | Oxervate | $24 | 1 payment
|
| Amgen | Tepezza | $23 | 1 payment
|
| Bausch & Lomb Americas | Vyzulta | $19 | 1 payment
|
| Harrow Eye | Vevye | $18 | 1 payment
|
2023: $479
| Glaukos | Istent Infinite Trabecular Micro-Bypass System Model Is3 | $300 | 2 payments
|
| Sun Pharmaceutical Industries | Cequa | $125 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $37 | 2 payments
|
| Horizon Therapeutics plc | Tepezza | $16 | 1 payment
|
2022: $37
| Abbvie | Durysta | $24 | 1 payment
|
| Alcon Vision | Clareon | $13 | 1 payment
|
2021: $375
| Allergan | Xen Glaucoma Treatment System | $250 | 3 payments
|
| Aerie Pharmaceuticals | Rocklatan | $125 | 1 payment
|
Professional record
- NPI
- 1891227211
- Licence
- NY 311321
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207WX0009X (207WX0009X); Federal specialty code 207W00000X (207W00000X); Student in a training program (390200000X)
- Mailing address
- 635 W 165th St # 96, New York, NY, 10032
- NPI first listed
- 2017-04-03
- NPI last updated
- 2023-06-02
- NPI record certified
- 2023-06-02
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 550 1st Ave, New York, NY, 10016 · 635 W 165th St # 96, New York, NY, 10032 · 710 Lawrence Expy, Santa Clara, CA, 95051